PPARG and diabetic kidney disease: Emerging evidence has shown the protective effects of PPAR-γ against diabetic kidney disease [26,27]; our quantitative RT-PCR and immunohistochemical studies (Figure 2 and Figure 3) showed that overexpression of miR-29a significantly reversed the attenuated PPAR-γ expression in diabetic mice.